Birdwatch Note
2024-11-29 06:03:34 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
COVID-19 has been shown to affect hemoglobin and the oxygenation properties of blood. These can cause lasting coagulopathies/myopathies. The mRNA ‘spike protein’ tells human cells how to make a small piece of the virus for an immune response to build antiviral antibodies. https://www.nature.com/articles/s41577-022-00762-9 https://healthcare.utah.edu/coronavirus/vaccine/mrna-vaccine
Written by 4BA5778434A4685A373B79A9DFC7E2EAB1D9F1D794D5D439AB0CE66771BCCE49
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1862332495116583133
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1862376841308172728
- noteId - 1862376841308172728
- participantId -
- noteAuthorParticipantId - 4BA5778434A4685A373B79A9DFC7E2EAB1D9F1D794D5D439AB0CE66771BCCE49 Participant Details
- createdAtMillis - 1732860214913
- tweetId - 1862332495116583133
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- COVID-19 has been shown to affect hemoglobin and the oxygenation properties of blood. These can cause lasting coagulopathies/myopathies. The mRNA ‘spike protein’ tells human cells how to make a small piece of the virus for an immune response to build antiviral antibodies. https://www.nature.com/articles/s41577-022-00762-9 https://healthcare.utah.edu/coronavirus/vaccine/mrna-vaccine
Note Ratings
| rated at | rated by | |
| 2024-11-30 20:22:57 -0600 | Rating Details | |
| 2024-11-29 20:43:15 -0600 | Rating Details | |
| 2024-11-29 12:29:03 -0600 | Rating Details | |
| 2024-11-29 09:28:46 -0600 | Rating Details | |
| 2024-11-29 09:16:40 -0600 | Rating Details | |
| 2024-11-29 08:29:33 -0600 | Rating Details | |
| 2024-11-29 08:28:35 -0600 | Rating Details | |
| 2024-11-29 08:26:26 -0600 | Rating Details | |
| 2024-11-29 07:44:00 -0600 | Rating Details | |
| 2024-11-29 07:29:58 -0600 | Rating Details | |
| 2024-11-29 07:24:55 -0600 | Rating Details | |
| 2024-11-29 06:52:34 -0600 | Rating Details | |
| 2024-11-29 06:52:25 -0600 | Rating Details | |
| 2024-11-29 06:32:27 -0600 | Rating Details | |
| 2024-11-29 05:53:32 -0600 | Rating Details | |
| 2024-11-29 04:51:08 -0600 | Rating Details | |
| 2024-11-29 04:07:31 -0600 | Rating Details | |
| 2024-11-29 03:30:39 -0600 | Rating Details | |
| 2024-11-29 02:52:45 -0600 | Rating Details | |
| 2024-11-29 02:06:07 -0600 | Rating Details | |
| 2024-11-29 01:36:58 -0600 | Rating Details | |
| 2024-11-29 01:33:19 -0600 | Rating Details | |
| 2024-11-29 01:29:35 -0600 | Rating Details | |
| 2024-11-29 01:22:20 -0600 | Rating Details | |
| 2024-11-29 01:20:30 -0600 | Rating Details | |
| 2024-11-29 01:20:16 -0600 | Rating Details | |
| 2024-11-29 01:08:20 -0600 | Rating Details | |
| 2024-11-29 14:41:17 -0600 | Rating Details | |
| 2024-11-29 14:22:08 -0600 | Rating Details | |
| 2024-11-29 08:21:03 -0600 | Rating Details | |
| 2024-11-29 07:19:30 -0600 | Rating Details | |
| 2024-11-29 06:16:54 -0600 | Rating Details | |
| 2024-11-29 06:07:23 -0600 | Rating Details | |
| 2024-11-29 02:43:58 -0600 | Rating Details | |
| 2024-11-29 02:34:15 -0600 | Rating Details | |
| 2024-11-29 01:37:03 -0600 | Rating Details | |
| 2024-11-29 01:29:13 -0600 | Rating Details | |
| 2024-11-29 01:17:57 -0600 | Rating Details | |
| 2024-11-29 01:16:23 -0600 | Rating Details | |
| 2024-11-29 00:51:02 -0600 | Rating Details | |
| 2024-11-29 19:28:03 -0600 | Rating Details | |
| 2024-11-29 14:22:27 -0600 | Rating Details | |
| 2024-11-29 11:45:26 -0600 | Rating Details | |
| 2024-11-29 02:51:41 -0600 | Rating Details | |
| 2024-11-29 01:57:07 -0600 | Rating Details | |
| 2024-11-29 01:47:12 -0600 | Rating Details | |
| 2024-11-29 01:20:40 -0600 | Rating Details |